262 related articles for article (PubMed ID: 28352668)
1. Genomic profiling reveals mutational landscape in parathyroid carcinomas.
Pandya C; Uzilov AV; Bellizzi J; Lau CY; Moe AS; Strahl M; Hamou W; Newman LC; Fink MY; Antipin Y; Yu W; Stevenson M; Cavaco BM; Teh BT; Thakker RV; Morreau H; Schadt EE; Sebra R; Li SD; Arnold A; Chen R
JCI Insight; 2017 Mar; 2(6):e92061. PubMed ID: 28352668
[TBL] [Abstract][Full Text] [Related]
2. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract][Full Text] [Related]
3. Complete genomic landscape of a recurring sporadic parathyroid carcinoma.
Kasaian K; Wiseman SM; Thiessen N; Mungall KL; Corbett RD; Qian JQ; Nip KM; He A; Tse K; Chuah E; Varhol RJ; Pandoh P; McDonald H; Zeng T; Tam A; Schein J; Birol I; Mungall AJ; Moore RA; Zhao Y; Hirst M; Marra MA; Walker BA; Jones SJ
J Pathol; 2013 Jul; 230(3):249-60. PubMed ID: 23616356
[TBL] [Abstract][Full Text] [Related]
4. Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.
Yu W; McPherson JR; Stevenson M; van Eijk R; Heng HL; Newey P; Gan A; Ruano D; Huang D; Poon SL; Ong CK; van Wezel T; Cavaco B; Rozen SG; Tan P; Teh BT; Thakker RV; Morreau H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E360-4. PubMed ID: 25387265
[TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
[TBL] [Abstract][Full Text] [Related]
7. The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.
Zhang JH; Seigneur EM; Pandey M; Loshakov A; Dagur PK; Connelly PS; Koo L; Panicker LM; Simonds WF
Cell Death Dis; 2012 Feb; 3(2):266. PubMed ID: 22297294
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid carcinoma: a clinical and genetic perspective.
Cetani F; Pardi E; Marcocci C
Minerva Endocrinol; 2018 Jun; 43(2):144-155. PubMed ID: 28949121
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract][Full Text] [Related]
10. Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.
Cui M; Hu Y; Bi Y; Wang W; Wang M; Zhang X; Zhang R; Wang P; Su Z; Gao X; Wang J; Li Q; Liao Q; Zhao Y
Int J Cancer; 2019 Feb; 144(3):525-532. PubMed ID: 30362515
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Pierobon M; Ramos C; Wong S; Hodge KA; Aldrich J; Byron S; Anthony SP; Robert NJ; Northfelt DW; Jahanzeb M; Vocila L; Wulfkuhle J; Gambara G; Gallagher RI; Dunetz B; Hoke N; Dong T; Craig DW; Cristofanilli M; Leyland-Jones B; Liotta LA; O'Shaughnessy JA; Carpten JD; Petricoin EF
Clin Cancer Res; 2017 Aug; 23(16):4919-4928. PubMed ID: 28446508
[No Abstract] [Full Text] [Related]
12. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
13. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
Zhang Y; Kwok-Shing Ng P; Kucherlapati M; Chen F; Liu Y; Tsang YH; de Velasco G; Jeong KJ; Akbani R; Hadjipanayis A; Pantazi A; Bristow CA; Lee E; Mahadeshwar HS; Tang J; Zhang J; Yang L; Seth S; Lee S; Ren X; Song X; Sun H; Seidman J; Luquette LJ; Xi R; Chin L; Protopopov A; Westbrook TF; Shelley CS; Choueiri TK; Ittmann M; Van Waes C; Weinstein JN; Liang H; Henske EP; Godwin AK; Park PJ; Kucherlapati R; Scott KL; Mills GB; Kwiatkowski DJ; Creighton CJ
Cancer Cell; 2017 Jun; 31(6):820-832.e3. PubMed ID: 28528867
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
[TBL] [Abstract][Full Text] [Related]
15. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.
Janku F; Kaseb AO; Tsimberidou AM; Wolff RA; Kurzrock R
Oncotarget; 2014 May; 5(10):3012-22. PubMed ID: 24931142
[TBL] [Abstract][Full Text] [Related]
17. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
Kang H; Pettinga D; Schubert AD; Ladenson PW; Ball DW; Chung JH; Schrock AB; Madison R; Frampton GM; Stephens PJ; Ross JS; Miller VA; Ali SM
Oncologist; 2019 Jun; 24(6):791-797. PubMed ID: 30373905
[TBL] [Abstract][Full Text] [Related]
18. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
[TBL] [Abstract][Full Text] [Related]
19. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T
Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
